Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide-N-oxide isomers in plasma

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 4, 1996, Pages 343-348

  Etienne, M C ^a   Oster, W ^b   Milano, G ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b USB Pharma Ltd   (United Kingdom)

Author keywords

Aromatase inhibitors; Chiral high performance liquid chromatography; Pharmacokinetics; Rogletimide; Stereoisomers

Indexed keywords

PYRIDOGLUTETHIMIDE;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STEREOISOMERISM;

AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; HUMANS; OXIDES; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM;

EID: 0029681740     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050493     Document Type: Article

References (18)

1. Aboul-Enein HY, Bakr SA, Nicholls PJ (1992) Direct Chromatographic resolution of racemic pyridoglutethimide using two cellulose-based chiral stationary phases. J Liq Chromatogr 15 : 2123-2131
2. Adam AM, Bradbrook ID, Rogers HJ (1985). High-performance liquid Chromatographic assay for simultaneous estimation of Ag and acetylAg in biological fluids. Cancer Chemother Pharmacol 15 : 176-178
3. Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26 : 663-668
4. Brodie AMH (1993) Aromatase, its inhibitors and their use in breast cancer treatment. Pharmacol Ther 60 : 501-515
5. Brodie AMH, Santen RJ (1994) Aromatase and its inhibitors in breast cancer treatment. Overview and perspective. Breast Res Cancer Treat 30 : 1-6
6. Dearnaley DP, Shearer RJ, Gallagher C, Oliver T, Gadd J (1994) A phase I/II study with rogletimide in patients with hormone resistant prostatic cancer (abstract) Ann Oncol 5 [Suppl 8]: 179
7. Dowsett M, MacNeil F, Mehta A, Newton C, Haynes B, Jones A, Jarman M, Lonning P, Powles TJ, Coombes RC (1991) Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl) piperidine-2,6-dione (pyridoglutethimide) in postmenopausal breast cancer patients. Br J Cancer 64 : 887-894
8. Etienne MC, Thyss A, Bertrand Y, Touraine R, Rubie H, Robert A. Milano G (1992) L-Folinic acid versus D,L-Folinic acid in rescue of high-dose methotrexate therapy in children. J Natl Cancer Inst 84 : 1190-1195
9. Etienne MC, Speziale N, Milano G (1993) HPLC of folinic acid diastereoisomers and 5-methyltetrahydrofolate in plasma. Clin Chem 39 : 82-86
10. Gauss PE, Gwyn KMEH (1994) Current perspectives on aromatase inhibitors in breast cancer. J. Clin Oncol 12 : 2460-2470
11. Haynes BP, Jarman M, Dowsett M, Mehta A, Lonning PE, Griggs LJ, Jones A, Powles T, Stein R, Coombes RC (1991) Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl) piperidine-2,6-dione in patients with postmenopausal breast cancer. Cancer Chemother Pharmacol 27 : 367-372
12. Lam YW (1988) Stereoselectivity: an issue of significant importance in clinical pharmacology. Pharmacotherapy 8 : 147-157
13. Lee EJD, Williams KM (1990) Chirality. Clinical pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 18 : 339-345
14. MacNeill FA, Jones AL, Jacobs S, Lonning PE, Powles TJ, Dowsett M (1992) The influence of Ag and its analogue rogletimide on peripheral aromatisation in breast cancer. Br J Cancer 66 : 692-697
15. Menge G, Dubois JP (1984) Determination of Ag and N-acetylAg in human plasma by high-performance liquid chromatography. J Chromatography 310:431-437
16. Miller AA, Miller B, Höffken K, Schmidt CG (1987) Clinical pharmacology of Ag in patients with metastatic breast cancer. Cancer Chemother Pharmacol 20 : 337-341
17. Strocchi E, Camaggi CM, Martoni A, et al (1991) Ag in advanced breast cancer: plasma levels and clinical results after low and high doses. Cancer Chemother Pharmacol 27 : 451-455
18. Wainer IW (1993) Stereoisomers in clinical oncology: why it is important to know what the right and left hands are doing. Ann Oncol 4 [Suppl 2]: S7-S13